BridgeMD
Compares treatment options for Rotator Cuff Tears
Official title RSA Vs RCR for Massive RCTs
ClinicalTrials.gov ID: NCT05807854
What this study is testing
- What it's testing
- Different treatment options are available for massive or irreparable rotator cuff tears. An arthroscopic or an open repair approach is possible in the majority of cases and functional outcomes are improved, particularly when a complete arthroscopic repair can be achieved.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 80
You may be able to join if
- 1 Patient voluntarily consents to participate
- 2 Patient with a massive and reparable non traumatic rotator cuff tears after failure of conservative treatment
- 3 Patients with the following pre-operative images: Three standardized X-rays series and Magnetic Resonance Imaging (MRI) or arthro Magnetic...
You likely can't join if
- 1 Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study
- 2 Revision rotator cuff repair
- 3 Patient consent withdrawal
- 4 Glenohumeral arthritis defined as stage \> 3 Hamada classification
- 5 Infection and neuropathic joints
- 6 Known or suspected non-compliance, drug or alcohol abuse
See the full eligibility criteria
- 1 Patient voluntarily consents to participate
- 2 Patient with a massive and reparable non traumatic rotator cuff tears after failure of conservative treatment
- 3 Patients with the following pre-operative images: Three standardized X-rays series and Magnetic Resonance Imaging (MRI) or arthro Magnetic Resonance Imaging without sign of traumatic lesions
- 1 Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study
- 2 Revision rotator cuff repair
- 3 Patient consent withdrawal
- 4 Glenohumeral arthritis defined as stage \> 3 Hamada classification
- 5 Infection and neuropathic joints
- 6 Known or suspected non-compliance, drug or alcohol abuse
- 7 Patients incapable of judgement or under tutelage
- 8 Inability to follow the procedures of the study
- 9 Enrolment of the investigator, his/her family members, employees and other dependent persons
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
- Meyrin, Canton of Geneva, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States; Meyrin, Canton of Geneva, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.